These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4602675)

  • 41. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrinolytic activity in diabetics before and after chlorpropamide therapy.
    Mehrotra TN; Mital HS; Mishra SD; Singh VS; Kumar M
    J Assoc Physicians India; 1978 May; 26(5):375-8. PubMed ID: 730717
    [No Abstract]   [Full Text] [Related]  

  • 43. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy.
    Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S
    J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults].
    Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME
    Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349
    [No Abstract]   [Full Text] [Related]  

  • 45. A long-term study of diabetics treated with chlorpropamide.
    Doenges JP; Knox LJ; Harrison CW
    IMJ Ill Med J; 1966 Jan; 129(1):25-30. PubMed ID: 4379038
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.
    Best JD; Judzewitsch RG; Pfeifer MA; Beard JC; Halter JB; Porte D
    Diabetes; 1982 Apr; 31(4 Pt 1):333-8. PubMed ID: 6759249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood sugar lowering effects of chlorpropamide and tolbutamide. A double blind cooperative study.
    Katz HM; Bissel G
    Diabetes; 1965 Oct; 14(10):650-7. PubMed ID: 5318832
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical use of the sulfonylurea drugs.
    Blumenthal SA; Moses AM
    Compr Ther; 1976 Jul; 2(2):53-8. PubMed ID: 954381
    [No Abstract]   [Full Text] [Related]  

  • 49. Observations of the mechanism of action of the sulfonylureas under clinical conditions.
    Jackson WP; Van Mieghem W; Keller P
    Metabolism; 1973 Sep; 22(9):1155-62. PubMed ID: 4199277
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of a drug marker in a clinical trial.
    Thompson RH; Stowers JM
    Scott Med J; 1971 May; 16(5):259-60. PubMed ID: 4932602
    [No Abstract]   [Full Text] [Related]  

  • 51. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
    Vailati G; Montini M; Pagani G; Caputo G
    Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
    Pettipierre B; Fabre J
    Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
    Balabolkin MI; Nedosugova LV
    Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136
    [No Abstract]   [Full Text] [Related]  

  • 54. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 55. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

  • 57. Insulin secretion in patients with diabetes insipidus during long-term treatment with chlorpropamide.
    Meinders AE; Cejka V; Bleijenberg AJ
    J Clin Endocrinol Metab; 1974 Apr; 38(4):539-44. PubMed ID: 4820657
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal.
    Paisey R; Elkeles RS; Hambley J; Magill P
    Diabetologia; 1978 Aug; 15(2):81-5. PubMed ID: 700275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of chlorpropamide therapy upon glucose-insulin relationships in adult diabetics.
    Goodner CJ; Chu PC; Conway MJ; Werrbach JH
    Adv Metab Disord; 1970; 1():Suppl 1:431+. PubMed ID: 4911190
    [No Abstract]   [Full Text] [Related]  

  • 60. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.